Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS (Tables)

v3.24.3
FINANCIAL INSTRUMENTS (Tables)
 9 Months Ended
Sep. 30, 2024
Investments, All Other Investments [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table sets forth the Company’s financial assets and liabilities, subject to fair value measurements on a recurring basis, by level within the fair value hierarchy:
September 30, 2024 (unaudited) December 31, 2023
Financial assets: (1)
Equity investment (2)
$ —  $ 200 
Total financial assets $ —  $ 200 
Financial liabilities: (1)
Derivative liabilities (3)
$ 6,563  $ 2,638 
Contingent consideration liabilities
 —  817 
Total financial liabilities $ 6,563  $ 3,455 
(1)The Company has no financial assets or liabilities in Level 1 or 2 within the fair value hierarchy as of September 30, 2024 and December 31, 2023, and there were no transfers between hierarchy levels during the nine months ended September 30, 2024 or year ended December 31, 2023.
(2)The Company adjusted its equity investment carrying value to reflect its equity balance of the investee, resulting in the recording of a loss on investment of $0 and $200 for the three and nine months ended September 30, 2024, respectively, and $0 for the three and nine months ended September 30, 2023. The loss on investment is included within other income (expense), net in the consolidated statements of operations and comprehensive income (loss).
(3)Refer to Note 9 - Derivative Liabilities.